- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Glenmark Pharmaceuticals Limited — Updates, 21-07-2026: Press Release
21-07-2026 | 08:41 am
21-07-2026 | 08:41 am
Glenmark received US FDA approval to expand RYALTRIS® Nasal Spray for children aged 6-12 with Seasonal Allergic Rhinitis. This significantly expands market reach, strengthens its US respiratory portfolio, and follows its recent transition to direct commercialization.
No comments yet. Be the first to comment!